Similar articles

• Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

  Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJ, Mohan P, Vinereanu D, Alexander JH. Lopes RD, et al. Lancet. 2012 Nov 17;380(9855):1749-58. doi: 10.1016/S0140-6736(12)60986-6. Epub 2012 Oct 2. Lancet. 2012. PMID: 23036896 Clinical Trial.
• Apixaban versus warfarin in atrial fibrillation.

  Vassiliou VS. Vassiliou VS. N Engl J Med. 2012 Jan 5;366(1):88; author reply 89. doi: 10.1056/NEJMc1112500. N Engl J Med. 2012. PMID: 22216849 No abstract available.
• Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).

  Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, Zhu J, Mohan P, Garcia D, Bartunek J, Vinereanu D, Husted S, Harjola VP, Rosenqvist M, Alexander JH, Granger CB; ARISTOTLE Committees and Investigators. Flaker G, et al. J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6. J Am Coll Cardiol. 2014. PMID: 24211508 Clinical Trial.
• Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

  Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY. Potpara TS, et al. Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Adv Ther. 2012. PMID: 22684583 Review.
• Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

  Proietti M, Romanazzi I, Romiti GF, Farcomeni A, Lip GYH. Proietti M, et al. Stroke. 2018 Jan;49(1):98-106. doi: 10.1161/STROKEAHA.117.018395. Epub 2017 Nov 22. Stroke. 2018. PMID: 29167388 Review.